JXI: Cuff, Nerve
What it covers
A nerve cuff is a tubular silicone rubber sheath used to encase a nerve for aid in repairing the nerve (e.g., to prevent ingrowth of scar tissue) and for capping the end of the nerve to prevent the formation of neuroma (tumors).
The identification in 21 CFR 882.5275, nerve cuff. FDA gives JXI no definition of its own, so the regulation’s describes it.
FDA flags JXI devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260245 | SILKBridge | KLISBio S.r.l. | Apr 9, 2026 | Traditional |
| K253363 | NeuroSpan Bridge | Auxilium Biotechnologies, Inc. | Jan 17, 2026 | Traditional |
| K251505 | VersaCoat Nerve Protector (VTP-44G2); VersaCoat Nerve Protector (VTP-12G1) | Alafair Biosciences | Jul 22, 2025 | Traditional |
| K251175 | VersaWrap Nerve Protector (VTP-2201); VersaWrap Nerve Protector (VTP-1201) | Alafair Biosciences | Jul 17, 2025 | Traditional |
| K242113 | Nerve Wrap (07-DW-001-TAB) | Biocircuit Technologies, Inc. | Apr 2, 2025 | Traditional |
| K243889 | Remplir (ON-152, 15 x 20 mm); Remplir (ON-203, 20 x 30 mm); Remplir (ON-304, 30 x 40 mm); Remplir (ON-405, 40 x 50 mm) | Orthocell, Ltd. | Apr 2, 2025 | Traditional |
| K233322 | Mochida Nerve Cuff | Mochida Pharmaceutical Co., Ltd. | Jun 21, 2024 | Traditional |
| K233533 | NerveTape | Biocircuit Technologies, Inc. | Feb 12, 2024 | Traditional |
| K230794 | Rebuilder Nerve Guidance Conduit | Celestray Biotech Company, LLC., | Jan 29, 2024 | Traditional |
| K232029 | VersaWrap Nerve Protector | Alafair Biosciences, Inc. | Nov 2, 2023 | Traditional |
Clearances by year
29 JXI 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 2 | 91 |
| 2025 | 4 | 99 |
| 2024 | 3 | 266 |
| 2023 | 3 | 122 |
| 2022 | 2 | 525 |
| 2020 | 1 | 90 |
| 2019 | 1 | 114 |
| 2018 | 1 | 89 |
| 2017 | 3 | 90 |
| 2016 | 3 | 117 |
| 2015 | 1 | 338 |
| 2014 | 3 | 309 |
| 2012 | 1 | 500 |
| 2011 | 1 | 73 |
Who submits
20 applicants cleared a JXI device since 2011. 62% of the clearances went to applicants in United States, then Australia (7%), Germany (7%) and Japan (7%). By type: Traditional 90% and Special 10%.
| Applicant | Clearances since 2011 |
|---|---|
| Axogen Corporation | 3 |
| Alafair Biosciences | 2 |
| Alafair Biosciences, Inc. | 2 |
| Biocircuit Technologies, Inc. | 2 |
| Collagen Matrix, Inc. | 2 |
| Cook Biotech Incorporated | 2 |
| Integra LifeSciences Corporation | 2 |
| Medovent GmbH | 2 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 882.5275.
Standards
21 CFR 882.5275 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent JXI clearances declared.
Ask about JXI
Questions about JXI
What is FDA product code JXI?
Product code JXI, “Cuff, Nerve” in FDA's classification database, is a Class II device type under 21 CFR 882.5275 (nerve cuff), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 40 clearances under JXI, 29 of them since 2011.
How many 510(k) clearances are there under JXI?
FDA’s 510(k) database listed 40 clearances under JXI as of Oct 29, 2026, 29 of them decided since 2011; the most recent decision was Apr 9, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a JXI 510(k)?
For the 6 JXI clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 99 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most JXI clearances?
Since 2011: Axogen Corporation (3), Alafair Biosciences (2), Alafair Biosciences, Inc. (2), Biocircuit Technologies, Inc. (2) and Collagen Matrix, Inc. (2). 20 applicants have cleared a JXI device in that time.